Amiram Eldor
Overview
Explore the profile of Amiram Eldor including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
25
Citations
769
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Herishanu Y, Misgav M, Kirgner I, Ben-Tal O, Eldor A, Naparstek E
Leuk Lymphoma
. 2004 Sep;
45(7):1407-11.
PMID: 15359641
Treatment with intensive chemotherapy regimens is frequently complicated by severe thrombocytopenia. During the period of severe thrombocytopenia, anticoagulant treatment is not uncommonly indicated for thromboembolic events or thromboprophylaxis in these...
2.
Lubetsky A, Hoffman R, Zimlichman R, Eldor A, Zvi J, Kostenko V, et al.
Thromb Res
. 2004 Jul;
113(6):371-8.
PMID: 15226091
Bleeding is the most serious adverse event of oral anticoagulants and is a major cause of morbidity and mortality in such patients. Rapid reversal of anticoagulation in bleeding patients or...
3.
Alikhan R, Cohen A, Combe S, Samama M, Desjardins L, Eldor A, et al.
Arch Intern Med
. 2004 May;
164(9):963-8.
PMID: 15136304
Background: There is limited information about risk factors for venous thromboembolism (VTE) in acutely ill hospitalized general medical patients. Methods: An international, randomized, double-masked, placebo-controlled trial (MEDENOX) has previously been...
4.
Ablin J, Cabili S, Eldor A, Lagziel A, Peretz H
Eur J Intern Med
. 2004 Apr;
15(1):22-27.
PMID: 15066644
Background: Patients carrying variant CYP2C9 alleles are prone to bleeding complications under standard warfarin treatment. Our aim was to test the feasibility of warfarin therapy in patients with severe, inherited...
5.
Bussel J, Eldor A, Kelton J, Varon D, Brenner B, Gillis S, et al.
Thromb Haemost
. 2004 Mar;
91(4):771-8.
PMID: 15045139
The general safety and efficacy of intravenous immunoglobulin (IGIV) as treatment for idiopathic thrombocytopenic purpura (ITP) has been well-studied. The current study compares the safety and efficacy of a novel...
6.
Alikhan R, Cohen A, Combe S, Samama M, Desjardins L, Eldor A, et al.
Blood Coagul Fibrinolysis
. 2003 Aug;
14(4):341-6.
PMID: 12945875
The Medical Patients with Enoxaparin (MEDENOX) trial was a randomized, placebo-controlled study that defined the risk of venous thromboembolism (VTE) in acutely ill, immobilized, general medical patients and the efficacy...
7.
Goor Y, Goor O, Eldor A
Autoimmun Rev
. 2003 Jul;
1(4):183-9.
PMID: 12848994
Heparin-induced thrombocytopenia (HIT) occurs in 1-5% of patients treated with heparin. The pathogenesis involves the formation of antibodies to heparin-platelet factor 4 complexes, and the major clinical sequelae are thrombotic....
8.
Kupferminc M, Eldor A
Semin Thromb Hemost
. 2003 Apr;
29(2):185-94.
PMID: 12709922
Severe obstetric complications, including preeclampsia, intrauterine growth retardation, abruptio placentae, and stillbirth, constitute a major cause of maternal and perinatal morbidity and death. The etiology of these severe obstetric complications...
9.
Schwartz J, Leber M, Gillis S, Giunta A, Eldor A, Bussel J
Am J Hematol
. 2003 Jan;
72(2):94-8.
PMID: 12555211
Splenectomy is the only treatment of ITP known to have "curative" effects in a substantial fraction of patients. However, the true long-term outcome is uncertain and controversial because published series...
10.
Perry C, Sklan E, Birikh K, Shapira M, Trejo L, Eldor A, et al.
Oncogene
. 2002 Dec;
21(55):8428-41.
PMID: 12466963
To study the regulation of acetylcholinesterase (AChE) gene expression in human brain tumors, 3' splice variants of AChE mRNA and potentially relevant transcription factor mRNAs were labeled in primary astrocytomas...